ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VNDA Vanda Pharmaceuticals Inc

4.88
0.00 (0.00%)
After Hours
Last Updated: 21:14:26
Delayed by 15 minutes
Share Name Share Symbol Market Type
Vanda Pharmaceuticals Inc NASDAQ:VNDA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.88 4.80 4.88 5.0319 4.79 5.00 1,284,365 21:14:26

Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day

14/10/2021 9:30pm

PR Newswire (US)


Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart


From May 2021 to May 2024

Click Here for more Vanda Pharmaceuticals Charts.

WASHINGTON, Oct. 14, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October 18, 2021. Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board, will take part in a virtual fireside chat at 1:30 PM ET.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Corporate Contact:

AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com

Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com

Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com

Cision View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-evercore-isis-catalyst-day-301400804.html

SOURCE Vanda Pharmaceuticals Inc.

Copyright 2021 PR Newswire

1 Year Vanda Pharmaceuticals Chart

1 Year Vanda Pharmaceuticals Chart

1 Month Vanda Pharmaceuticals Chart

1 Month Vanda Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock